Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Tables)

v3.21.1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2020
Stockholders' Equity Note [Abstract]  
Schedule of equity purchase option activity
    Number of     Weighted     Weighted        
    Equity     Average     Average        
    Purchase     Exercise     Remaining     Intrinsic  
    Options     Price     Term (Yrs)     Value  
Outstanding, January 1, 2020     600,000     $ 11.50                  
Granted    
-
                         
Exercised    
-
                         
Expired    
-
                         
Forfeited    
-
                         
Outstanding, December 31, 2020     600,000     $ 11.50       1.8     $
-
 
                                 
Exercisable, December 31, 2020     600,000     $ 11.50       1.8     $
-
 

 

Schedule of option activity
          Weighted     Weighted        
          Average     Average        
    Number of     Exercise     Remaining     Intrinsic  
    Options     Price     Term (Yrs)     Value  
Outstanding, January 1, 2020     2,480,000     $ 4.34       9.86     $
           -
 
Granted     200,000       2.15                  
Exercised    
-
     
-
                 
Expired    
-
     
-
                 
Forfeited     (250,000 )     4.47                  
Outstanding, December 31, 2020     2,430,000     $ 4.15       8.92     $
-
 
                                 
Exercisable, December 31, 2020     557,500     $ 4.33       2.84     $
-
 

 

Schedule of options outstanding and exercisable
Options Outstanding     Options Exercisable  
      Outstanding     Weighted Average     Exercisable  
Exercise     Number of     Remaining Life     Number of  
Price     Options     In Years     Options  
$ 2.11       80,000      
-
     
-
 
$ 2.17       120,000      
-
     
-
 
$ 4.09       1,890,000       2.89       472,500  
$ 5.66       340,000       2.56       85,000  
          2,430,000       2.84       557,500  

Schedule of fair value of options granted
    For the Years Ended  
    December 31,  
    2020     2019  
Risk free interest rate     0.55 - 0.69%       1.74 - 1.77%  
Expected term (years)     6.25       6.25  
Expected volatility     38%       36%  
Expected dividends     0.00%       0.00%  

 

Schedule of non-vested restricted stock activity
    Number of
Restricted Stock
    Weighted Average
Grant Date
Fair Value
 
Non-vested balance, January 1, 2020     80,393     $ 5.66  
Granted     199,143       2.03  
Vested     (80,393 )     5.66  
Forfeited    
-
     
-
 
Non-vested balance, December 31, 2020     199,143     $ 2.03  

Schedule of warrant activity
    Number of Warrants     Weighted Average Exercise Price     Weighted Average Remaining Life in Years     Intrinsic
Value
 
Outstanding, January 1, 2020     18,637,003     $ 11.50       4.6     $
-
 
Issued     1,454,546       4.13                  
Exercised    
-
     
-
                 
Cancelled    
-
     
-
                 
Outstanding, December 31, 2020     20,091,549     $ 10.97       3.7     $
-
 
                                 
Exercisable, December 31, 2020     20,091,549     $ 10.97       3.7     $
-